Stephen V Faraone, PhD
- Distinguished Professor and Vice Chair of Research of Psychiatry and Behavioral Sciences
- Professor of Neuroscience Graduate Program
- Professor of Neuroscience and Physiology
Research Programs and Affiliations
- Biomedical Sciences Program
- Medical Genetics Research Center
- Neuroscience Program
- Psychiatry and Behavioral Sciences
Education & Fellowships
- Post Graduate Training: Brown University, Clinical Psychology
- Postdoctoral Fellow: Brown University, Psychiatric Epidemiology and Genetics
- PhD: University of Iowa, 1982, Clinical Psychology
- MA: University of Iowa, 1980, Clinical Psychology
- BA: SUNY Stony Brook, 1978, Psychology
Prof. Faraone studies the nature and causes of mental disorders in childhood and has ongoing research in psychiatric genetics, psychopharmacology, with a current focus on applications of data driven computational models (DDCMs) including classical machine learning and deep learning. His ongoing DDCM projects are: 1) predict neuro-developmental disorders and test hypotheses about brain differences in the disorders; 2) predict disorders from genome-wide association data and to test hypotheses about epistasis from such data; 3) predict comorbid psychiatric and somatic conditions among patients with ADHD and 4) to predict response to medications that treat ADHD. He also has a research program to create and disseminate quality measures for the diagnosis and treatment of ADHD in adults.
Stephen V. Faraone, PhD CV
Link to PubMed (Opens new window. Close the PubMed window to return to this page.)
Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Vice Chair for Research in the Department of Psychiatry. He is also Senior Scientific Advisor to the Research Program Pediatric Psychopharmacology at the Massachusetts General Hospital and a lecturer at Harvard Medical School. Prof. Faraone studies the nature and causes of mental disorders in childhood and has ongoing research in psychiatric genetics, psychopharmacology, with a current focus on machine learning approaches to these areas.
An author on over 1000 journal articles, editorials, chapters and books, he was the eighth highest producer of High Impact Papers in Psychiatry from 1990 to 1999 as determined by the Institute for Scientific Information (ISI, Science, 2000, Vol 288, pg 959). In 2005, ISI determined him to be the second highest cited author for Attention Deficit Hyperactivity Disorder (https://web.archive.org/web/20160120233137/http://www.esi-topics.com/add/interviews/StephenFaraone.html). From 2014 to 2019 he has been listed as a highly cited researcher by Thomson Reuters/Clarivate Analytics. In 2019 and 2020, his citation metrics placed him in the top 0.01% of scientists across all fields (https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000384). ;In 2020, expertscape indicated he was the top-rated expert in ADHD, worldwide http://expertscape.com/ex/attention+deficit+disorder+with+hyperactivity. His lifetime H-Index as of March 2021 was 216.
Prof. Faraone is Editor for the journal Neuropsychiatric Genetic and Program Director of the educational website www.adhdinadults.com. He is President of the World Federation of ADHD and was a Founding Board member for the American Professional Society of ADHD and Related Disorders. He founded the ADHD Molecular Genetics Network in the 1990s and was a founding member of the Psychiatric Genomics Consortium's Coordinating Committee.
In 2002, Prof. Faraone was inducted into the CHADD Hall of Fame in recognition of outstanding achievement in medicine and education research on attention disorders. In 2008, he received the SUNY Upstate President's Award for Excellence and Leadership in Research. In 2009 he was awarded Alumni Fellow status at the University of Iowa in recognition of his outstanding contributions to society and his profession. In 2010 he received the Chancellor's Award for Excellence in Scholarship and Creative Activities from the State University of New York. In 2013, he was awarded the title of Distinguished Professor by the State University of New York, which is conferred upon faculty having achieved national or international prominence and a distinguished reputation within the individual's chosen field. In 2018 he received the Lifetime Achievement Award from the International Society of Psychiatric Genetics and in 2019 he received the Paul Hoch Award from the American Psychopathological Association.